Bio-Medical Applictions Of Tennessee Inc in Memphis, Tennessee - Dialysis Center

Bio-Medical Applictions Of Tennessee Inc is a medicare approved dialysis facility center in Memphis, Tennessee and it has 19 dialysis stations. It is located in Shelby county at 4601 Quince Road, Memphis, TN, 38117. You can reach out to the office of Bio-Medical Applictions Of Tennessee Inc at (901) 767-0223. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applictions Of Tennessee Inc has the following ownership type - Profit. It was first certified by medicare in January, 2016. The medicare id for this facility is 442731 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applictions Of Tennessee Inc
Location	4601 Quince Road, Memphis, Tennessee
No. of Dialysis Stations	19
Medicare ID	442731
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applictions Of Tennessee Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1639591951
Organization Name	Fresenius Medical Care Central Memphis
Doing Business As	Bio-medical Applications Of Tennessee, Inc.
Address	4601 Quince Rd Memphis, Tennessee, 38117
Phone Number	(901) 767-0223

Dialysis patients with Hemoglobin data	20
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	25

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	33
  Adult patient months included in Kt/V greater than or equal to 1.2	222
  Percentage of adult patients getting regular hemodialysis at the center	99
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applictions Of Tennessee Inc with elevated calcium levels.

Patients with hypercalcemia	38
Hypercalcemia patient months	243
Hypercalcemia patients with serumcalcium greater than 10.2 mg	2
Patients with Serumphosphor	40
Patients with Serumphosphor less than 3.5 mg/dL	6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	35
Patients with Serumphosphor from 5.6 to 7 mg/dL	20
Patients with Serumphosphor greater than 7 mg/dL	12

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	39
Patient months included in arterial venous fistula and catheter summaries	235
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	78
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	12

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	20
Hospitalization Rate in facility	71.2 (As Expected)
Hospitalization Rate: Upper Confidence Limit	356.6
Hospitalization Rate: Lower Confidence Limit	16.1

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applictions Of Tennessee Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	8.8 (As Expected)
Readmission Rate: Upper Confidence Limit	39.3
Readmission Rate: Lower Confidence Limit	.3